# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria

Extent: E+W+S+N.I.

At least one of the following four:
Demonstration of Cryptosporidium oocysts in stool;
Demonstration of Cryptosporidium in intestinal fluid or small-bowel biopsy specimens;
Detection of Cryptosporidium nucleic acid in stool;
Detection of Cryptosporidium antigen in stool.

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.9/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.9/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.